Atlas Trials

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment

Clinical trial NCT03160014 · UNKNOWN

Trial details

NCT number
NCT03160014
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2015-06-01
Primary completion
2017-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.